DaVita
DVA
#1976
Rank
C$14.10 B
Marketcap
C$224.17
Share price
-3.37%
Change (1 day)
38.57%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$19.47

According to DaVita's latest financial reports the company's current EPS (TTM) is C$19.90. In 2025 the company made an earnings per share (EPS) of C$14.51 a decrease over its 2024 EPS that were of C$15.82.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$19.4734.16%
2025C$14.51-8.25%
2024C$15.8244.94%
2023C$10.9127.26%
2022C$8.57-35.56%
2021C$13.3144.1%
2020C$9.2319.7%
2019C$7.71540.48%
2018C$1.20-76.07%
2017C$5.03-19.31%
2016C$6.24242.52%
2015C$1.82-62.87%
2014C$4.9013.43%
2013C$4.328.45%
2012C$3.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$34.64 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$17.59-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$49.77 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.70-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA